| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |